Results 71 to 80 of about 16,335 (84)
Some of the next articles are maybe not open access.
Current recommendations and recent progress in endometrial cancer
Ca-A Cancer Journal for Clinicians, 2019Gini F Fleming
exaly
Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates
Ca-A Cancer Journal for Clinicians, 2006David M Goldenberg
exaly
Recent Progress in the Management of Advanced Renal Cell Carcinoma
Ca-A Cancer Journal for Clinicians, 2007Brian I Rini
exaly
Design of anti-icing surfaces: smooth, textured or slippery?
Nature Reviews Materials, 2016Jack Alvarenga +2 more
exaly
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
Nature Reviews Clinical Oncology, 2016Celine Boutros +2 more
exaly
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Nature Reviews Clinical Oncology, 2018Kabir A Khan, Robert S Kerbel
exaly
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Nature Reviews Clinical Oncology, 2019Gerasimos P Sykiotis +2 more
exaly
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Nature, 2018Alexander C Huang, Bin Wu, Ting Li
exaly
A framework for the development of effective anti-metastatic agents
Nature Reviews Clinical Oncology, 2018Robin L Anderson +2 more
exaly